Takahiro Tsuchiya

Dr. Takahiro Tsuchiya


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2024 in Cancers
Verified
Journal Article
Open access
PDF file
TTTakahiro Tsuchiya
Takahiro Tsuchiya
DKDaisuke Kawauchi
Daisuke Kawauchi
MOMakoto Ohno
Makoto Ohno
YMYasuji Miyakita
Yasuji Miyakita
Masamichi TakahashiMasamichi Takahashi
Masamichi Takahashi
YNYOSHITAKA NARITA
YOSHITAKA NARITA
Isocitrate dehydrogenase (IDH) wild-type glioblastoma (GBM) is a highly aggressive brain tumor with a high recurrence rate despite adjuvant treatment. This study aimed to evaluate the risk factors for non-local recurrence of GBM. In the present study, we analyzed 104 GBMs with a single lesion (non-multifocal or multicentric). Univariate analysis revealed that subventricular zone (SVZ) involvement was significantly associated with non-local recurrence (hazard ratio [HR]: 2.09 [1.08–4.05]). Tumors in contact with the trigone of the lateral ventricle tended to develop subependymal dissemination (p = 0.008). Ventricular opening via surgery did not increase the risk of non-local recurrence in patients with SVZ involvement (p = 0.190). A systematic review was performed to investigate the risk of non-local recurrence, and 21 studies were identified. A meta-analysis of previous studies confirmed SVZ involvement (odds ratio [OR]: 1.30 [1.01–1.67]) and O-6-methylguanine DNA methyltransferase promoter methylation (OR: 1.55 [1.09–2.20]) as significant risk factors for local recurrence. A time-dependent meta-analysis revealed a significant association between SVZ involvement and dissemination (HR: 1.69 [1.09–2.63]), while no significant association was found for distant recurrence (HR: 1.29 [0.74–2.27]). Understanding SVZ involvement and specific tumor locations associated with non-local recurrence provides critical insights for the management of GBM.

15 February 2026 in Neurologia medico-chirurgica
Verified
Journal Article
Open access
PDF file
TTTakahiro Tsuchiya
Takahiro Tsuchiya
TKTsukasa Koike
Tsukasa Koike
YHYudai Hirano
Yudai Hirano
YKYasuaki Karasawa
Yasuaki Karasawa
ATAtsumi Takenobu
Atsumi Takenobu
ATAkira Teraoka
Akira Teraoka
In Japan, which has become a super-aging society, the incidence of spontaneous intracerebral hemorrhage among older adults is increasing. Managing these patients is often complicated by frailty and systemic comorbidities. Although these issues pose unique challenges, there is limited research on spontaneous intracerebral hemorrhage in this population, leaving their clinical characteristics and prognoses unclear. This retrospective study reviewed spontaneous intracerebral hemorrhage patients aged ≥75 years who were admitted to our institution from April 2004 to March 2024. Demographics, clinical presentation, imaging findings, and in-hospital outcomes were analyzed to identify risk factors for both 30-day and complication-related mortality. A total of 501 patients were included in the study, with 213 (42.5%) categorized as the oldest-old (age ≥85 years). Over the 2-decade study period, the proportion of oldest-old spontaneous intracerebral hemorrhage patients increased, and this age group exhibited a high risk of complication-related mortality (16.9%). Multivariate analysis identified age ≥85 years (odds ratio: 4.25, 95% confidence interval: 2.12-8.51, p < 0.001), Glasgow Coma Scale score ≤8 at admission (odds ratio: 2.27, 95% confidence interval: 1.19-4.34, p = 0.013), and serum albumin ≤3.5 g/dL at admission (odds ratio: 2.12, 95% confidence interval: 1.07-4.19, p = 0.031) as independent risk factors for complication-related mortality. The prognosis of spontaneous intracerebral hemorrhage in older adults is significantly worse in individuals aged ≥85 years. Older patients with spontaneous intracerebral hemorrhage are at a heightened risk of complication-related mortality, which is primarily associated with advanced age, neurological severity, and hypoalbuminemia.

15 April 2022 in Surgical Neurology International
Verified
Journal Article
Open access
TTTakahiro Tsuchiya
Takahiro Tsuchiya
SMSatoru Miyawaki
Satoru Miyawaki
YSYuki Shinya
Yuki Shinya
YTYu Teranishi
Yu Teranishi
ATArisa Tomioka
Arisa Tomioka
NSNobuhito Saito
Nobuhito Saito
Background: Ancient schwannoma (AS) is a subtype of schwannoma with degenerative features, which often progresses slowly over a long period of time. Intracranial AS is a rare benign tumor and there are no detailed reports of AS originating from the vestibular nerve. Case Description: Herein, we present the case of a patient with the right vestibular schwannoma with multiple meningiomas and review three previous cases of intracranial AS. Near-total resection was performed for vestibular schwannoma and the pathological findings were AS (World Health Organization Grade I). Five months postoperatively, gamma knife radiosurgery was performed for a recurrent lesion of the right vestibular schwannoma in the internal auditory meatus. Although AS is known to be a benign pathology, there are cases of rapid growth and early recurrence, as the one presented here. The high Ki-67 index (up to 5%) and the presence of cysts may be related to the rapid progression of intracranial AS. Conclusion: Therefore, careful follow-up is necessary even if adequate removal is achieved. In addition to pathological studies, the genetic background of intracranial AS warrants future investigations. Further accumulation of cases is necessary to clarify the clinical features of intracranial AS.

28 August 2024 in Neurosurgery Practice
Verified
Journal Article
Open access
TTTakahiro Tsuchiya
Takahiro Tsuchiya
Masamichi TakahashiMasamichi Takahashi
Masamichi Takahashi
MOMakoto Ohno
Makoto Ohno
SYShunsuke Yanagisawa
Shunsuke Yanagisawa
SOSho Osawa
Sho Osawa
YNYOSHITAKA NARITA
YOSHITAKA NARITA
BACKGROUND AND OBJECTIVES: Deep white matter (DWM) is perfused by the medullary arteries from the cortex, and ischemia sometimes occurs after glioma resection. However, the clinical significance of postoperative medullary artery–related ischemia has not been well studied. We retrospectively reviewed cases of delayed DWM ischemia after awake craniotomy to elucidate the clinical characteristics, mechanisms, and management of delayed ischemia. METHODS: We identified 4 cases of intra-axial brain tumors, mainly gliomas, that underwent tumor resection by awake craniotomy at our hospital and developed DWM ischemic symptoms after surgery, despite no worsening of neurological symptoms at the end of surgery. RESULTS: Four patients (3 men and 1 woman) presented with glioblastoma, oligodendroglioma, astrocytoma, and brain metastasis. The median age at surgery was 47.5 years (41-73 years). The tumors were located in the watershed area in the frontal lobe (n = 2) and the parietal lobe (n = 2), all of which were left-sided (n = 4). DWM ischemic symptoms, such as motor dysfunction, aphasia, dysarthria, and dysgraphia, developed at an average of 24 hours (14-48 hours) after resection by awake craniotomy. All 4 patients showed symptom improvement within a week after surgery and completely recovered within a month. CONCLUSION: DWM ischemia is caused by sacrifice of the medullary artery, which feeds the tumor and adjacent brain tissue during tumor resection, and should be considered when delayed aphasia or paralysis occurs postoperatively. These symptoms are often transient and recovery usually occurs. Tumors located in the frontal or parietal lobes, particularly in the watershed area, should be carefully monitored for postoperative ischemia.

24 July 2024 in Cancers
Verified
Journal Article
Open access
PDF file
SOSho Osawa
Sho Osawa
YMYasuji Miyakita
Yasuji Miyakita
Masamichi TakahashiMasamichi Takahashi
Masamichi Takahashi
MOMakoto Ohno
Makoto Ohno
SYShunsuke Yanagisawa
Shunsuke Yanagisawa
YNYOSHITAKA NARITA
YOSHITAKA NARITA
Awake surgery contributes to the maximal safe removal of gliomas by localizing brain function. However, the efficacy and safety thereof as a treatment modality for glioblastomas (GBMs) have not yet been established. In this study, we analyzed the outcomes of awake surgery as a treatment modality for GBMs, response to awake mapping, and the factors correlated with mapping failure. Patients with GBMs who had undergone awake surgery at our hospital between March 2010 and February 2023 were included in this study. Those with recurrence were excluded from this study. The clinical characteristics, response to awake mapping, extent of resection (EOR), postoperative complications, progression-free survival (PFS), overall survival (OS), and factors correlated with mapping failure were retrospectively analyzed. Of the 32 participants included in this study, the median age was 57 years old; 17 (53%) were male. Awake mapping was successfully completed in 28 participants (88%). A positive response to mapping and limited resection were observed in 17 (53%) and 13 participants (41%), respectively. The EOR included gross total, subtotal, and partial resections and biopsies in 19 (59%), 8 (25%), 3 (9%), and 2 cases (6%), respectively. Eight (25%) and three participants (9%) presented with neurological deterioration in the acute postoperative period and at 3 months postoperatively, respectively. The median PFS and OS were 15.7 and 36.9 months, respectively. The time from anesthetic induction to extubation was statistically significantly longer in the mapping failure cohort than that in the mapping success cohort. Functional areas could be detected during awake surgery in participants with GBMs. Thus, awake mapping influences intraoperative discernment, contributes to the preservation of brain function, and improves treatment outcomes.

3 April 2025 in Neurosurgery Practice
Verified
Journal Article
Open access
SOSho Osawa
Sho Osawa
MOMakoto Ohno
Makoto Ohno
YMYasuji Miyakita
Yasuji Miyakita
Masamichi TakahashiMasamichi Takahashi
Masamichi Takahashi
SYShunsuke Yanagisawa
Shunsuke Yanagisawa
YNYOSHITAKA NARITA
YOSHITAKA NARITA
BACKGROUND AND OBJECTIVES: Frameless neuronavigation–guided stereotactic biopsy (SB) is a common surgical technique for diagnosing intracranial lesions. A frameless SB is generally performed under general anesthesia; however, no reports are available on the efficacy and safety of frameless SBs under local anesthesia (LA). This study reports the surgical outcomes, diagnostic yield, and feasibility of molecular analyses after performing a frameless SB under LA (SB-LA). METHODS: The study retrospectively included patients who underwent a frameless SB-LA at our institute between March 2015 and January 2024. The clinical characteristics, intraoperative findings, completion rate of surgical procedure, complications, diagnostic yield, and feasibility of molecular analysis were analyzed retrospectively. RESULTS: The study included 80 patients. Surgical procedures were completed in 79 patients (98.7%); the diagnosis was confirmed in 76 cases (95.0%). The diagnoses included diffuse gliomas (n = 38, 47.5%), primary central nervous system lymphomas (PCNSL; n = 27, 33.8%), other brain tumors (n = 4, 5.0%), demyelinating diseases (n = 2, 2.5%), and normal brain/gliosis (n = 5, 6.3%). All samples were sufficient for basic molecular analyses of isocitrate dehydrogenase 1/2, telomerase reverse transcriptase promoter, H3 histone family 3A, serine/threonine kinase B-RAF, and O-6-methylguanine deoxyribonucleic acid methyltransferase promoter methylation in gliomas and myeloid differentiation primary response gene 88 for PCNSLs. A comprehensive genomic profiling test using next-generation sequencing was attempted in 9 cases and was feasible in 8. Asymptomatic hemorrhages occurred in 14 patients (17.5%); no symptomatic hemorrhage occurred. Neurological deficits were observed in 1 patient (1.3%) who developed symptomatic small cerebral infarction. The median period from the first visit to our hospital to surgery was 3 days (range 0-12) for PCNSL and 6.5 days (range 0-21) for primary glioblastoma, isocitrate dehydrogenase wild-type. CONCLUSION: Frameless SB-LAs can be performed safely with a high diagnostic yield and feasibility for molecular analysis. Frameless SB-LAs improve early diagnoses and therapeutic interventions without compromising molecular information.